About a decade ago, Joan Riggs, a 64-year-old from Lemoyne, started to have shaky hands. At first, it was an annoyance.

Dear Dr. Roach: I read your answer to a recent question about seasonal affective disorder (SAD). You mentioned that folks can get SAD in the summer but didn't discuss treatment options. I've tried ...

Feb 9 (Reuters) - Regenxbio (RGNX.O), opens new tab said on Monday the U.S. Food and Drug Administration had declined to approve its gene therapy for a rare disease called Hunter syndrome, citing ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Acadia Pharmaceuticals said that drug regulators in Europe are leaning toward rejecting its application for a neurodevelopmental disorder treatment. The company said Monday it was informed by a ...

The CEO of drugmaker Eli Lilly said that Medicare’s coverage of Ozempic and other GLP-1s could have major impacts on weight loss treatment options. Specifically, it will help Eli Lilly launch a brand ...

Havana syndrome is characterized by a set of unexplained neurological and cognitive symptoms reported by diplomats and government staff, primarily in Havana, Cuba. The exact cause remains undetermined ...

The American Heart Association/American Stroke Association released its 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke published the guideline on Monday. “This ...

MILAN--(BUSINESS WIRE)--With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for Waskyra™, a gene therapy to treat Wiskott-Aldrich ...

The Baltimore Ravens made the controversial yet overdue decision to fire John Harbaugh after an 8-9 campaign that resulted in a stunning postseason absence. A popular Super Bowl pick coming into the ...

Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...

– Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing ...